Literature DB >> 26583670

International Multicenter Study on the Impact of Extracapsular Lymph Node Involvement in Primary Surgery Adenocarcinoma of the Esophagus on Overall Survival and Staging Systems.

Philippe R Nafteux1, Antoon M Lerut, Johnny Moons, Arnulf H Hölscher, Elfriede Bollschweiler, Mark I van Berge Henegouwen, Sjoerd M Lagarde, Jan J van Lanschot, Mathieu Messager, Christophe Mariette, Xavier B D'Journo, Pascal A Thomas, Paul R De Leyn.   

Abstract

OBJECTIVE: The current pathological lymph node (pN) staging is based on the number of positive lymph nodes but does not take into consideration characteristics of the involved lymph nodes itself. The current study aims to examine the prognostic value of extracapsular lymph node involvement (EC-LNI) and intracapsular lymph node involvement (IC-LNI) for esophageal adenocarcinoma treated by primary surgery.
METHODS: From the databases of five European high volume centers, 1639 adenocarcinoma patients with primary R0-resection were withheld after excluding 90-day mortality. Oncologic variables, including number of resected lymph nodes, number of resected positive lymph nodes, and EC-LNI/IC-LNI were examined. The Union Internationale contre le Cancer (UICC) 7th edition prognostic staging was used as baseline staging system. Statistical analysis was performed by Cox proportional hazards modeling and verified using the Random Survival Forest technique.
RESULTS: EC-LNI showed significantly worse overall 5-year survival compared with IC-LNI overall (13.4% vs 37.2%, P < 0.0001), including in each pN-category [16.4% vs 45.6% in pN1 (P < 0.0001), 16.1% vs 23.8% (P = 0.047) in pN2 (P = 0.065), and 8.7% vs 26.3% in pN3 categories, respectively]. pN1 IC-LNI patients show a 5-year overall survival comparable (P = 0.92) with stage IIB (ie, pT3N0). Reclassifying the UICC prognostic stages according to these findings into an adapted staging model showed a significant (P < 0.0001) increase in homogeneity, discriminatory ability, and monotonicity compared with the original UICC TNM 7th edition prognostic staging.
CONCLUSIONS: These data suggest that lymph node capsular status is an important prognostic factor and should be considered for the future edition of the TNM staging system for esophageal cancer.

Entities:  

Mesh:

Year:  2015        PMID: 26583670     DOI: 10.1097/SLA.0000000000001463

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  7 in total

1.  The significance of pathological extracapsular vs. intracapsular lymph node involvement in patients with resectable esophageal cancer after neoadjuvant therapy.

Authors:  Puja Gaur Khaitan; Thomas J Watson
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

2.  Extracapsular lymph node involvement after neoadjuvant chemoradiation in esophageal carcinoma: how to interpret?

Authors:  Lieven P Depypere; Philippe R Nafteux
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

3.  Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.

Authors:  T W Rice; H Ishwaran; W L Hofstetter; D P Kelsen; C Apperson-Hansen; E H Blackstone
Journal:  Dis Esophagus       Date:  2016-11       Impact factor: 3.429

4.  The emerging field of radiomics in esophageal cancer: current evidence and future potential.

Authors:  Peter S N van Rossum; Cai Xu; David V Fried; Lucas Goense; Laurence E Court; Steven H Lin
Journal:  Transl Cancer Res       Date:  2016-08       Impact factor: 1.241

5.  Achieving adequate lymph node dissection in treating esophageal squamous cell carcinomas by radical lymphadenectomy: Beyond the scope of numbers of harvested lymph nodes.

Authors:  Zheng Lin; Weilin Chen; Yuanmei Chen; Xiane Peng; Siyou Yan; Fei He; Rong Fu; Yixian Jiang; Zhijian Hu
Journal:  Oncol Lett       Date:  2019-06-12       Impact factor: 2.967

6.  Cancer Survival Data Representation for Improved Parametric and Dynamic Lifetime Analysis.

Authors:  Lode K J Vandamme; Peter A A F Wouters; Gerrit D Slooter; Ignace H J T de Hingh
Journal:  Healthcare (Basel)       Date:  2019-10-28

7.  Survival outcomes for patients with four treatments in stages I-III esophageal squamous cell carcinoma: a SEER analysis.

Authors:  Jingyang Wu; Jiansheng Yang; Xianbin Lin; Liang'an Lin; Wentan Jiang; Chengke Xie
Journal:  Transl Cancer Res       Date:  2021-05       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.